Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000229639 | SCV000286662 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2016-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000253847 | SCV000319982 | uncertain significance | Cardiovascular phenotype | 2018-09-12 | criteria provided, single submitter | clinical testing | The p.H5457R variant (also known as c.16370A>G), located in coding exon 63 of the TTN gene, results from an A to G substitution at nucleotide position 16370. The histidine at codon 5457 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be probably damaging and tolerated by PolyPhen and SIFT in silico analyses, respectively. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
Eurofins Ntd Llc |
RCV000725708 | SCV000701091 | uncertain significance | not provided | 2016-10-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725708 | SCV000714716 | likely benign | not provided | 2021-07-21 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27535533) |
CHEO Genetics Diagnostic Laboratory, |
RCV000769020 | SCV000900393 | uncertain significance | Cardiomyopathy | 2016-06-16 | criteria provided, single submitter | clinical testing | |
Genetics and Genomics Program, |
RCV001293151 | SCV001434141 | uncertain significance | Hypertrophic cardiomyopathy | criteria provided, single submitter | research | ||
Revvity Omics, |
RCV000725708 | SCV003826575 | uncertain significance | not provided | 2022-01-28 | criteria provided, single submitter | clinical testing |